An image of an unfolded box for Tydemy birth control tablets from in a July 29, 2023 recall notice on the Food and Drug Administration website.
(Food and Drug Administration)
By Wyatte Grantham-Philips
Federal regulators are warning consumers that now-recalled lots of the Tydemy birth control pill “may have reduced effectiveness” due to decreased levels of a key ingredient of the product.
Lupin Pharmaceuticals, which manufactures Tydemy, notified customers on Saturday that it was voluntarily recalling two batches of the oral contraceptive — after one lot tested low for ascorbic acid and high “for a known impurity.”
Inadequate ascorbic acid “could potentially impact the effectiveness" of the birth control, Lupin said in a company announcement published by the Food and Drug Administration, which could result in unexpected pregnancy.
In an addition alert published by the FDA on Tuesday, regulators confirmed that no reports of adverse effects related to the recalled lots of Tydemy had been reported to date.
Even though this recall impacts just two batches of one brand, it’s important for people using Tydemy birth control pills to check their stock — and contact a health care provider if needed.
The Tydemy lots under recall were distributed across the U.S. from June 2022 through May 2023. The products can be identified by their lot codes — L200183 and L201560 — and expiration dates of January 2024 and September 2024, respectfully.
Lupin is instructing Tydemy patients to continue taking their medication — and immediately contact a health care provider “for advice regarding an alternative contraceptive method," the FDA said, if their birth control was impacted by the recall or if they experience any problems taking the product.
According to Lupin's announcement last week, the company is also notifying wholesalers, distributors, pharmacies and other retailers and is arranging for the return for all of the products impacted by the recall. Contact information for reimbursement requests can be found on the recall notice.
The Associated Press reached out to Lupin for additional comment Thursday.
Two Democratic senators are pushing for legislation to change the Federal Aviation Administration's standards around seat sizing and spacing on aircrafts. Sens. Tammy Duckworth and Tammy Baldwin have introduced a new bill, which would also require the FAA to set new standards for aircraft evacuations that are more realistic in case of emergencies.
Jury selection in the groundbreaking trial of a former sheriff's deputy charged with failing to confront the killer of 14 students and three staff members at a Florida high school five years ago got off to a speedy start Wednesday, with the preliminary round concluding in just one day.
Centrist Democrats and Republicans pushed it to approval over blowback from conservatives and some progressives. The Senate is expected to act quickly by the end of the week.
We know life can be tough sometimes, so we'd like to take a moment to share One Good Thing happening in the world today. A Wisconsin woman has gone viral after taking in a stray cat that had been coming to her door every single day for a few weeks.
Families of passengers who died in the crash of a Boeing 737 Max in Ethiopia can seek damages for the pain and terror suffered by victims in the minutes before the plane flew nose-down into the ground, a federal judge has ruled.
Former first lady Rosalynn Carter has been diagnosed with dementia, and the Carter Center said her family wanted to share her health news to increase important conversations around the country. According to the CDC, there are about 5.8 million people in the United states living with dementia. Here to help us understand this complex disease is Dr. Jen Caudle, family physician and associate professor at Rowan University.
